FREMONT, Calif.--(BUSINESS WIRE)--Penguin Computing, a leading provider of on-demand High Performance Computing services in the cloud, and Numira Biosciences, a leader in 3D imaging solutions for Pre-Clinical Life Sciences, announced a formal partnership to bring graphics-intense data on-demand to Life Sciences customers. This unique platform will leverage a convergence of enabling technologies from Penguin Computing's HPC as a Service offering, POD; Numira Biosciences’ AltaPortal product; and Nvidia’s GPU technology to deliver advanced pre-clinical imaging services to researchers at pharmaceutical and biotechnology companies around the globe.
Researchers will benefit from the cutting edge graphics, GPU power, global accessibility and reliability of Penguin Computing's HPC as a Service platform, POD. Numira's AltaPortal product provides a secure web interface for managing projects and exploring datasets, media and documents. By leveraging POD, AltaPortal will enable researchers to interactively navigate rich 3D data from microCT scans with overlaid analytics customized to the task at hand. The data will be delivered as a media stream to the client's web browser, eliminating the need to transfer large and potentially proprietary datasets over networks, and allowing them to be secured in a central location.
"Penguin has enjoyed steady growth in the genomics sector with its POD offering. Adding Numira's medical imaging software and services to our POD partner portfolio will enhance our breadth in the bioinformatics market and further establish POD as a destination for that set of users" said Matt Jacobs, SVP of Corporate Development for Penguin Computing.
"At Numira we’ve built our reputation delivering rich quantitative analytics for preclinical medical imaging. With our AltaPortal web service, we’re taking it to the next level; our customers will be able to interactively explore and quantitatively assess their preclinical imaging data with our custom 3D visual analytic tools. Penguin’s POD service offers the ideal platform for our rendering-on-demand engine,” said David Weinstein, Numira’s Chief Technology Officer.
To learn more about Penguin Computing’s HPC as a Service, POD or to contact Penguin click here, and to learn more about Numira Biosciences and AltaPortal, please click here.
About Penguin Computing
For well over a decade Penguin Computing has been dedicated to delivering complete, integrated Enterprise and High Performance Computing (HPC) solutions that are innovative, cost effective, and easy to use. Penguin offers a complete end-to-end portfolio of products and solutions including workstations, rackmount servers, custom server designs, power efficient rack solutions and turnkey clusters. Penguin also offers the Scyld suite of software products for efficient provisioning and infrastructure monitoring. Additionally, Penguin Computing on Demand (POD), is a public HPC cloud that is available instantly and as needed. Penguin counts some of the world’s most demanding organizations as its customers, including AOL, Yelp, Caterpillar, Life Technologies, Dolby, Lockheed Martin and the US Air Force.
Penguin Computing is a registered trademark of Penguin Computing, Inc. Penguin on Demand is a pending trademark in the US. All other trademarks are property of their respective owners. Other product or company names mentioned may be trademarks or trade names of their respective companies.
About Numira Biosciences
Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries. Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their drug development programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and others. Moreover, we are a recognized leader in high-resolution, 3D quantitative imaging and high-performance computing. Numira, a privately held company, is venture-backed by Signal Peak Ventures, the Tech Coast Angels, Pasadena Angels, and Crocker Ventures. For more information on Numira, please visit www.numirabio.com.